Company news
Achieve Life Sciences, Inc. news in 2022
Achieve Life Sciences, Inc.'s news releases, calls and decks from 2022, newest first.
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
December 20, 2022
Achieve Life Sciences Announces Private Placement of $18.9 Million
November 14, 2022
Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update
November 13, 2022
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
November 7, 2022
Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
September 26, 2022
Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update
August 10, 2022
Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation
June 28, 2022
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
May 31, 2022
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
May 25, 2022
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
May 11, 2022
Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers
April 26, 2022
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 14, 2022
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors
March 13, 2022
Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
March 10, 2022
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
March 9, 2022
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
February 23, 2022
Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award
February 2, 2022
Achieve Life Sciences Announces Participation in February Investor Conferences
February 1, 2022
Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
January 24, 2022
Achieve Life Sciences Announces Completion of Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial of Cytisinicline for Smoking Cessation
January 3, 2022
Calls in 2022
- Achieve Life Sciences (NASDAQ:ACHV) Q3 2022 Earnings Call
Nov 14, 2022
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q2 2022 Earnings Call
Aug 11, 2022
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q1 2022 Earnings Call
May 12, 2022
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q4 2021 Earnings Call
Mar 10, 2022
Transcript
Decks in 2022
- Technical Presentation (April 2022)
Technical · 11 slides · Apr 27, 2022